This webinar is put on by Innovative Medicines Canada
Canadians with government drug plans wait two years on average to access new medicines. Are you interested in learning more about these delays and how different provinces compare?
The Conference Board of Canada’s, Access and Time to Patient, Prescription Drugs in Canada, 2024 report unpacks the main delays in patient access to medicines. You are invited to attend a data briefing and Q&A with the Conference Board of Canada on this important issue.